Haug
Bengt Erik Haug, Tromso NO
Patent application number | Description | Published |
---|---|---|
20100267621 | Antimicrobial Compounds and Formulations - The invention relates to the use of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto at least two bulky and lipophilic groups and having at least one more cationic than anionic moiety, in the manufacture of a medicament for destabilising microbial cell membranes and the use as a membrane acting antimicrobial agent of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto a super bulky and lipophilic group comprising at least 9 non-hydrogen atoms and having at least two more cationic than anionic moieties and to methods of treatment involving such molecules, in particular peptides including peptide derivatives, and peptidomimetics. | 10-21-2010 |
20120108520 | Antimicrobial Compounds and Formulations - The invention relates to the use of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto at least two bulky and lipophilic groups and having at least one more cationic than anionic moiety, in the manufacture of a medicament for destabilising microbial cell membranes and the use as a membrane acting antimicrobial agent of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto a super bulky and lipophilic group comprising at least 9 non-hydrogen atoms and having at least two more cationic than anionic moieties and to methods of treatment involving such molecules, in particular peptides including peptide derivatives, and peptidomimetics. | 05-03-2012 |
Bengt Erik Haug, Tertnes NO
Patent application number | Description | Published |
---|---|---|
20110318364 | NONAPEPTIDE WITH ANTI-TUMOUR ACTIVITY - The present invention relates to peptides or peptide like molecules and their uses in therapy, in particular as anti-tumour agents. | 12-29-2011 |
20120149908 | TRIAZOLYLPIPERIDINE DERIVATIVES AND METHOD FOR MAKING THE SAME - In a first aspect, the present invention relates to a method for the preparation of alkynylpiperidine and alkynylpiperidine derivatives. In particular, a method is provided for preparing alkynylpiperidine derivatives starting from epoxide compounds. Further, the alkynylpiperidine derivatives according to the present inventions are substituted trans-3-4-alkynylpiperidine derivatives. In another aspect, triazolylpiperidine compounds and methods for said preparation are provided. In particular, the triazolylpiperidine compounds according to the present invention are obtained by reacting an alkynylpiperidine derivatives with an organic azid, preferably, in the presence of a Cu (I) or Ru catalyst. In a preferred embodiment, 1,4-disubstituted or 1,5-disubstituted 1,2,3-triazolylpiperidine compounds are provided. | 06-14-2012 |
Claire Haug, Saint-Louis FR
Patent application number | Description | Published |
---|---|---|
20110082221 | IN SITU GELLING SYSTEMS AS SUSTAINED DELIVERY FOR FRONT OF EYE - An ophthalmic formulation particularly well suited for use as a delivery vehicle in the sustained delivery of ophthalmic active agents to the eye. The formulations comprise an alginate, wherein the guluronic acid content is in a range of about 35 percent to about 45 percent, and an excipient, preferably gellan gum or scleroglucan, with an active agent dissolved or suspended therein that together provide an in situ-gelling system for use in the eye. | 04-07-2011 |
20120270796 | Suspension Type Topical Formulations Comprising Cyclic Depsipeptide - The invention relates to novel topical pharmaceutical compositions in which the active agent is a cyclic depsipeptide of formula (II) | 10-25-2012 |
20140162959 | SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPDIPEPTIDE - The invention relates to novel topical pharmaceutical compositions in which the active agent is a cyclic depsipeptide of formula (II) | 06-12-2014 |
Claire Haug, Basel CH
Patent application number | Description | Published |
---|---|---|
20110112121 | Pharmaceutical Compositions and Solid Forms - The present invention relates to pharmaceutical compositions of 6-(6-hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, to the use of 6-(6-hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide and compositions of 6-(6-hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide in therapeutic applications, especially indications with a dysregulation/overexpression of VEFG, (neo)-vascularisation and VEGF driven angiogenesis and to methods for manufacturing such compositions, the invention further relates to specific forms of 6-(6-hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide and to the manufacturing and use of such forms. The present invention also relates to a new process to produce 6-(6-hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide. | 05-12-2011 |
Erick Bengt Haug, Tortnes NO
Patent application number | Description | Published |
---|---|---|
20110172145 | ANTIMICROBIAL COMPOUNDS - The present invention relates to a compound of formula (I) AA-AA-AA-X—Y—Z wherein, in any order, 2 of said AA (amino acid) moieties are cationic amino acids and 1 of said AA is an amino acid with a lipophilic R group, the R group having 14-27 non-hydrogen atoms; X is a N atom, which may be substituted by a branched or unbranched C | 07-14-2011 |
Franz-Joseph Haug, Saint-Blaise CH
Patent application number | Description | Published |
---|---|---|
20110226319 | MULTIPLE-JUNCTION PHOTOELECTRIC DEVICE AND ITS PRODUCTION PROCESS - A multiple-junction photoelectric device includes a substrate on which a first conducting layer is deposited, at least two elementary photoelectric devices of n-i-p or n-p configuration, on which a second conducting layer is deposited, and at least one intermediate layer between two adjacent elementary photoelectric devices. The intermediate layer has, on the incoming light side, top and bottom faces, the latter having a peak-valley roughness >150 nm, the top and bottom faces having respectively a surface morphology including inclined elementary surfaces so α | 09-22-2011 |
20120186642 | SOLAR CELL AND ITS PRODUCTION PROCESS - A solar cell includes a support ( | 07-26-2012 |
Friedrich Haug, Thoiry FR
Patent application number | Description | Published |
---|---|---|
20150192116 | Cryogenic Cooling Pump and Method | 07-09-2015 |
Ingrild Haug, Trondheim NO
Patent application number | Description | Published |
---|---|---|
20090220576 | EMULSION - The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester. | 09-03-2009 |
Ingvild Haug, Trondheim NO
Patent application number | Description | Published |
---|---|---|
20090238866 | CHEWABLE CAPSULES - The invention provides an orally administrable chewable capsule comprising a capsule shell enclosing an oil-in-water emulsion in which the aqueous phase is gelled, or an oil droplet-containing dried residue of such an emulsion. | 09-24-2009 |
Ingvild Haug, Tromso NO
Patent application number | Description | Published |
---|---|---|
20140005179 | ORAL PHARMACEUTICAL DISPERSION COMPOSITIONS | 01-02-2014 |
Ingvild Johanne Haug, Tromso NO
Patent application number | Description | Published |
---|---|---|
20110045067 | SOFT GEL CAPSULES - The invention relates to soft gelatin capsules containing at least one pharmaceutical, wherein the capsule shell includes carrageenan and cold water fish gelatin or a mixture of cold fish gelatin and warm fish gelatin. | 02-24-2011 |
20110268770 | CHEWABLE GELLED EMULSIONS - An oral pharmaceutical composition in unit dose form, each unit dose comprising a statin within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion, one or both of the oil phase and the water phase whereof comprises a physiologically tolerable omega-3 acid ester. | 11-03-2011 |
20110268771 | CHEWABLE GELLED EMULSIONS - An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion. | 11-03-2011 |
20130273025 | ORAL VETERINARY PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS - This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs. | 10-17-2013 |
20140163108 | ORAL PHARMACEUTICAL DISPERSION COMPOSITIONS - The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic. | 06-12-2014 |
20150037438 | CHEWABLE GELLED EMULSIONS - An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion. | 02-05-2015 |
Ingvild Johanne Haug, Sandefjord NO
Patent application number | Description | Published |
---|---|---|
20090131541 | Gelatin-containing topical composition - This invention provides a topical pharmaceutical or cosmetic composition comprising a pharmaceutically or cosmetically active agent and a gelling agent, characterized in that said gelling agent comprises a fish gelatin and a polysaccharide. | 05-21-2009 |
Martin Haug, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20160126946 | CONTROL OF A HALF-BRIDGE - A control for an electrical consumer includes a first switching device for connecting an output for the consumer to a first potential, a second switching device for connecting the output to a second potential, a control device for activating the switching devices, a first scanning device for providing a first signal as a function of a switching state of the first switching device, a second scanning device for providing a second signal as a function of a switching state of the second switching device, and a comparator device for determining a difference in the switch-on times of the switching devices on the basis of the determined signals. | 05-05-2016 |
Rune Morten Haug, Trondheim NO
Patent application number | Description | Published |
---|---|---|
20110241453 | ELECTRICAL MACHINE AND METHOD FOR THE MANUFACTURE OF STATOR SECTIONS THEREFOR - Electrical machine with a rotor with magnets carried by an annular carrier, in which a magnetic field is created over an air gap between two rotor parts, at which an ironless stator with windings is arranged. A space saving machine is achieved with a stator which is assembled of sections with channels for circulation of coolant, and which has windings with an annular, compact central part providing the active part of the stator. A method for manufacturing stator sections for such electrical machines is described, where a winding is embedded in an electrically insulating casting material for providing a rigid element. A coil is arranged in one part of a bisected shell housing or a bisected casting mold, and the shell housing or mould is closed, casting material is introduced through an opening and the inner part of the housing or mould is subject to underpressure and possibly vibration. | 10-06-2011 |
Thomas Peter Haug, Langnau Im Emmental CH
Patent application number | Description | Published |
---|---|---|
20090083198 | Process for franking, printing, and/or producing images on flat mail items - Mail items ( | 03-26-2009 |
Tor Haug, Kvaloysletta NO
Patent application number | Description | Published |
---|---|---|
20100093642 | NOVEL POLYPEPTIDES - The present invention relates to novel polypeptides, nucleic acids encoding said peptides, cell lines, vectors, pharmaceutical compositions and antibodies. The invention may be used to treat fungus, infections, ulcers, wounds, cancer and/or inflammation in a patient in need thereof. | 04-15-2010 |